Results 61 to 70 of about 600,809 (212)

Edoxaban: an update on the new oral direct factor Xa inhibitor. [PDF]

, 2014
Edoxaban is a once-daily oral anticoagulant that rapidly and selectively inhibits factor Xa in a concentration-dependent manner. This review describes the extensive clinical development program of edoxaban, including phase III studies in patients with ...
A. John Camm, AC Skanes, AG Turpie, AJ Camm, AK Kakkar, AT Cohen, B Laulicht, BF Gage, BI Eriksson, BI Eriksson, BI Eriksson, BI Eriksson, BS Stambler, C Kearon, CB Granger, CT Ruff, DE Salazar, G Agnelli, G Agnelli, G Lu, G Raskob, G Raskob, H Masumoto, H Zahir, Henri Bounameaux, J Mendell, J Mendell, J Mendell, J Mendell, J Mendell, J Mendell, J Stampfuss, JH Alexander, JI Weitz, JL Mega, K Ogata, KL Furie, LT Grip, M Crowther, M Hori, M Pirmohamed, MR Lassen, MR Lassen, MR Lassen, MR Lassen, MR Patel, MS Bathala, MU Zafar, N Chung, N Matsushima, R Caterina De, R Caterina De, RP Giugliano, S Kaatz, S Schulman, S Schulman, S Schulman, SE Kimmel, SJ Connolly, SJ Connolly, SJ Connolly, SZ Goldhaber, T Fuji, T Fuji, T Fukuda, T Hulle van der, T Mikkaichi, T Wilke, T Yamashita, TI Verhoef, W Mueck, Y Falck-Ytter, Y Kuroda   +72 more
core   +1 more source

Postmarketing surveillance of the oxidative stability for cooking oils, frying oils, and vanaspati supplied in the retail market

Food Science & Nutrition, 2019
In this study, postmarketing surveillance (PMS) was conducted in terms of the parameters which are reliable indicators of the oxidative stability of cooking oils, frying oils, and vanaspati samples.
H. Tavakoli, M. Naderi, S. Jafari, M. H. Naeli   +3 more
semanticscholar   +1 more source

The role of databases in drug postmarketing surveillance [PDF]

Pharmacoepidemiology and Drug Safety, 2001
AbstractThis paper describes the role of databases used for postmarketing surveillance of drugs at the United States Food and Drug Administration (FDA). First we describe the Adverse Event Reporting System (AERS), the largest database of adverse event reports in the world.
Rodriguez, Evelyn M., Staffa, Judy A., Graham, David J.   +2 more
openaire   +3 more sources

Commentary: Use of registries to investigate the past and develop the future. [PDF]

, 2011
International audienceIdeally, collection of clinical data should be an integral part of healthcare systems. Without systematic collection of individual patient data and outcome it is impossible for individual doctors, healthcare providers, or regulatory
Daubert, Jean-Claude, James, Stefan, van de Werf, Frans   +2 more
core   +2 more sources

Information and communication technology solutions for outdoor navigation in dementia [PDF]

, 2016
INTRODUCTION: Information and communication technology (ICT) is potentially mature enough to empower outdoor and social activities in dementia. However, actual ICT-based devices have limited functionality and impact, mainly limited to safety. What is an
Aloulou, Alwin, American Psychiatric Association A, Arribas-Ayllon, Aspden, Austin, Baglio, Boger, Borson, Bosboom, Bradley, Brittain, Buschert, Chapman, Cipriani, Claudio Babiloni, Cosentino, De Raedt, Dodge, Drago, Free, Gillespie, Hattink, Heise, Henderson, Hoey, Honig, Jeffrey Kaye, Jesse Hoey, Kasper, Khosravi, Kirste, Koldrack, Krüger, Lancioni, Lancioni, Laske, Levinson, Lively, Milne, Mitchell, Niemeijer, Oliver K. Burmeister, Olsson, Passini, Patterson, Petersen, Rizzolatti, Robert, Russel, Schikhof, Serna, Shani, Smit, Solanas, Stefan Teipel, Strohminger, Thomas Kirste, Tung, Veldkamp   +59 more
core   +1 more source

Safety of opioid patch initiation in Australian residential aged care [PDF]

, 2015
Explores opioid use by aged care facility residents before and after initiation of transdermal opioid patches. Abstract Objective: To explore opioid use by aged care facility residents before and after initiation of transdermal opioid patches. Design:
Elizabeth Roughead, Lisa Pont, Svetla Gadzhanova   +2 more
core   +1 more source

Glycoprotein IIb/IIIa Inhibitors Use and Outcome after Percutaneous Coronary Intervention for Non-ST Elevation Myocardial Infarction [PDF]

, 2014
Aims. We investigate the effect of glycoprotein IIb/IIIa (GP IIb/IIIa) inhibitors on long-term outcomes following percutaneous coronary intervention (PCI) after non-ST elevation myocardial infarction (NSTEMI). Meta-analyses indicate that these agents are
Antoniou, S, Gallagher, S, Howard, JP, Jones, DA, Knight, C, Mathur, A, Rathod, K, Weerackody, R, Wragg, A, Wright, P   +9 more
core   +4 more sources

Regulating risks in pharmaceutical law : the need of an optimal interplay between products safety and products liability [PDF]

, 2011
Published online: 7 June 2011The aim of this paper is to call for the need of a theoretical model of pharmaceutical products safety in which the two systems of regulation and liability operate complementarily. The question is why two legal tools that are
RIZZI, Marco
core  

Safety and effectiveness of apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A regulatory postmarketing surveillance, the STANDARD study

Journal of Arrhythmia, 2019
Apixaban, a non‐vitamin K oral anticoagulant (NOAC), was approved in Japan in 2012 for the prevention of thromboembolic events in patients with nonvalvular atrial fibrillation (NVAF). However, the safety and effectiveness of apixaban in clinical practice
H. Inoue, Michiaki Umeyama, Takako Yamada, H. Hashimoto, Akira Komoto, M. Yasaka   +5 more
semanticscholar   +1 more source

What is the addiction risk associated with tramadol? [PDF]

, 2005
Tramadol (Ultram, generic and with acetaminophen in Ultracet) carries a risk of substance abuse (strength of recommendation [SOR]: B, based on case report surveillance programs).
Mackler, Leslie, McDiarmid, Todd
core